This site is intended for healthcare professionals
News

Tirzepatide enters SURPASS-CVOT, the phase III cardiovascular outcomes trial,- Eli Lilly

Read time: 1 mins
Last updated:10th Jun 2020
Published:10th Jun 2020
Condition: Diabetes Type 2 + CV Disease
Type: drug
Register free for full access to medthority.com